blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4285912

EP4285912 - COMPOSITIONS AND METHODS FOR MODULATING ATAXIN 3 EXPRESSION [Right-click to bookmark this link]
StatusThe application has been published
Status updated on  03.11.2023
Database last updated on 07.10.2024
Most recent event   Tooltip28.09.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Ionis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad, CA 92010 / US
For all designated states
Academisch Ziekenhuis Leiden (h.o.d.n. LUMC)
Albinusdreef 2
2333 ZA Leiden / NL
[2023/49]
Inventor(s)01 / RIGO, Frank
Carlsbad, 92010 / US
02 / PRAKASH, Thazha P.
Carlsbad, 92010 / US
03 / VAN ROON-MOM, Wilhemina Maria, Clasina
1944 Beverwijk / NL
04 / TOONEN, Lodewijk Julius, Anton
2235CD Valkenburg / NL
 [2023/49]
Representative(s)Marks & Clerk LLP
15 Fetter Lane
London EC4A 1BW / GB
[2023/49]
Application number, filing date23188922.123.09.2016
[2023/49]
Priority number, dateUS201562232956P25.09.2015         Original published format: US 201562232956 P
US201662307279P11.03.2016         Original published format: US 201662307279 P
US201662315521P30.03.2016         Original published format: US 201662315521 P
[2023/49]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP4285912
Date:06.12.2023
Language:EN
[2023/49]
Type: A3 Search report 
No.:EP4285912
Date:10.07.2024
Language:EN
[2024/28]
Search report(s)(Supplementary) European search report - dispatched on:EP11.06.2024
ClassificationIPC:C12N15/113, C12N9/48, A61K31/712
[2024/16]
CPC:
C12N15/113 (EP,US); A61K31/712 (EP,US); C12N9/485 (EP,US);
C12Y304/19012 (EP,US); C12N2310/11 (EP,US); C12N2310/321 (EP,US);
C12N2310/3231 (EP,US); C12N2310/3341 (EP,US); C12N2310/3525 (EP,US) (-)
Former IPC [2023/49]A61K31/712
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/49]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR MODULATION VON ATAXIN 3-EXPRESSION[2023/49]
English:COMPOSITIONS AND METHODS FOR MODULATING ATAXIN 3 EXPRESSION[2023/49]
French:COMPOSITIONS ET MÉTHODES DE MODULATION DE L'EXPRESSION DE L'ATAXINE 3[2023/49]
Parent application(s)   TooltipEP16849742.8  / EP3353303
Fees paidRenewal fee
28.11.2023Renewal fee patent year 03
28.11.2023Renewal fee patent year 04
28.11.2023Renewal fee patent year 05
28.11.2023Renewal fee patent year 06
28.11.2023Renewal fee patent year 07
27.09.2023Renewal fee patent year 08
27.09.2024Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2013138353  (SHIRE HUMAN GENETIC THERAPIES [US]);
 [A]US8901095  (COREY DAVID R [US], et al);
 [A]WO2015053624  (ACADEMISCH ZIEKENHUIS LEIDEN [NL]);
by applicantUS3687808
 US4845205
 US5034506
 US5130302
 US5134066
 US5166315
 US5175273
 US5185444
 US5367066
 US5432272
 US5434257
 US5457187
 US5457191
 US5459255
 US5484908
 US5502177
 US5525711
 US5552540
 US5587469
 US5587470
 US5594121
 US5596091
 US5614617
 US5645985
 US5681941
 US5698685
 US5750692
 US5763588
 US5808027
 US5811534
 US5830653
 US5859221
 WO9914226
 US5948903
 US6005087
 US6005096
 US6166199
 US6268490
 US6525191
 US6531584
 US2003158403
 US2003175906
 US6670461
 US6770748
 US6794499
 WO2004106356
 US7034133
 US7053207
 WO2007134181
 US2008039618
 US7399845
 WO2008101157
 US7427672
 US7547684
 US7569686
 US7572582
 US7666854
 US7696345
 US7741457
 US7750131
 US7875733
 US7939677
 US8022193
 US8030467
 US8034909
 WO2011133876
 US8080644
 US8088746
 US8088904
 US8124745
 US8153365
 US8268980
 US8278283
 US8278426
 US8440803
 US8501805
 US2013203836
 US8530640
 US8546556
 USRE44779E
 US8796437
 WO2014179620
 US9005906
 US9012421
 US2015191727
 WO2015106128
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.